Pleryon Therapeutics
PrivateLast Round
Series A
Aug 22, 2025
Total Funding Raised
$20.86M
Company Overview
Pleryon Therapeutics is a biotechnology company that develops novel polymer-based therapeutics and drug delivery systems to address unmet medical needs in ophthalmology and orthopedics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pleryon Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Pleryon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 22, 2025 | ||||
| Pre Seed | Apr 1, 2022 |
Key People
Founding team and executive leadership
Pleryon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaitai Capital | Pre Seed |
| Lapam Capital | Pre Seed |
| Zero2IPO Venture Capital | Pre Seed |
| Efung Capital | Series A |
Pleryon Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pleryon Therapeutics's valuation, stock price, and market status.